TARA ZICKERMAN: Open Payments
NPI 1093840605 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 13 payments from 12 companies in 2025. Trend: 2023 $594 · 2024 $552 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $58 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Janssen Biotech, Inc. | 1 | $31 |
| PharmaEssentia USA Corporation | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| GENZYME CORPORATION | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $19 |
Products named: Onivyde, DARZALEX, BESREMI, Enhertu, LUTATHERA, SARCLISA, VERZENIO, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
